![]() |
Volumn 30, Issue 7, 2002, Pages 771-777
|
The pharmacokinetics of a thiazole benzenesulfonamide β3-adrenergic receptor agonist and its analogs in rats, dogs, and monkeys: Improving oral bioavailability
a
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BENZENESULFONAMIDE DERIVATIVE;
BETA 3 ADRENERGIC RECEPTOR STIMULATING AGENT;
N [4 [2 [2 (3 PYRIDINYL)MORPHOLIN 4 YL]ETHYL]PHENYL] 4 [4 [4 (TRIFLUOROMETHYL)PHENYL]THIAZOL 2 YL]BENZENESULFONAMIDE;
N [4 [2 [[2 HYDROXY 2 (PYRIDIN 2 YL)ETHYL]AMINO]ETHYL]PHENYL] 4 [4 (4 TRIFLUOROMETHYLPHENYL)THIAZOL 2 YL]BENZENESULFONAMIDE;
N [4 [2 [[2 HYDROXY 2 (PYRIDIN 3 YL)ETHYL]AMINO]ETHYL]PHENYL] 4 [4 (4 TRIFLUOROMETHYLPHENYL)THIAZOL 2 YL]BENZENESULFONAMIDE;
N [4 [2 [ETHYL [2 HYDROXY 2 (3 PYRIDINYL)ETHYL]AMINO]ETHYL]PHENYL] 4 [4 [4 (TRIFLUOROMETHYL)PHENYL]THIAZOL 2 YL]BENZENESULFONAMIDE;
PRODRUG;
THIAZOLE DERIVATIVE;
UNCLASSIFIED DRUG;
BENZENESULFONAMIDE;
BETA 3 ADRENERGIC RECEPTOR;
BETA ADRENERGIC RECEPTOR STIMULATING AGENT;
SULFONAMIDE;
ANIMAL EXPERIMENT;
ARTICLE;
CONTROLLED STUDY;
DOG;
DRUG ABSORPTION;
DRUG BIOAVAILABILITY;
DRUG CLEARANCE;
DRUG DESIGN;
DRUG DETERMINATION;
DRUG EXCRETION;
DRUG METABOLISM;
DRUG STRUCTURE;
FIRST PASS EFFECT;
HYDROGEN BOND;
INTESTINE ABSORPTION;
LIVER BLOOD FLOW;
LIVER METABOLISM;
MALE;
MONKEY;
NONHUMAN;
PRIORITY JOURNAL;
RAT;
SPECIES DIFFERENCE;
ANIMAL;
BIOAVAILABILITY;
CHEMISTRY;
DRUG POTENTIATION;
DRUG SCREENING;
MACACA;
METABOLISM;
ORAL DRUG ADMINISTRATION;
PHYSIOLOGY;
SPRAGUE DAWLEY RAT;
ADMINISTRATION, ORAL;
ADRENERGIC BETA-AGONISTS;
ANIMAL;
BIOLOGICAL AVAILABILITY;
DOGS;
DRUG EVALUATION, PRECLINICAL;
MACACA MULATTA;
MALE;
RATS;
RATS, SPRAGUE-DAWLEY;
RECEPTORS, ADRENERGIC, BETA-3;
SULFONAMIDES;
THIAZOLES;
ANIMALS;
ANIMALIA;
CANIS FAMILIARIS;
|
EID: 0035987890
PISSN: 00909556
EISSN: None
Source Type: Journal
DOI: 10.1124/dmd.30.7.771 Document Type: Article |
Times cited : (18)
|
References (26)
|